What is the long-term trend for Inter Parfums's indefinite- lived intangible impairment?

Over 2 years (2023 to 2025), Inter Parfums's indefinite- lived intangible impairment has grown at a 7.6% compound annual growth rate (CAGR), from $386.34M to $447.63M.

Inter Parfums IPAR Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

L3Harris TechnologiesLHX

$11.15B-4.4%

Rockwell AutomationROK

$1.33B-16.9%

Bath & Body WorksBBWI

$165M0.0%

Mondelez InternationalMDLZ

$22.04B+2.8%

Mohawk IndustriesMHK

$690.6M+1.8%

The Travelers CompaniesTRV

$628M-1.3%

Other financials

Income statement

See full

Revenue$344.9M+1.8%

Gross profit$224.6M+4.0%

Operating income$74.1M-1.3%

Net income$43.4M+2.1%

EPS (diluted)$1.35+2.3%

Balance sheet

See full

Cash & equivalents$79.9M-17.3%

Total debt$132.6M-5.5%

Total equity$881.6M+11.8%

Total assets$1.5B+7.1%

Cash flow

See full

Operating cash flow$85.0K+101%

CapEx$1.4M-5.3%

Free cash flow-$1.3M+85.5%

Valuation

See full

Market cap$3.18B-20.4%

Profitability

See full

Gross margin64%-0.2pp

Operating margin18%-1.2pp

Net margin11.3%0.0pp

FCF margin13.2%-2.2pp

Returns & leverage

See full

Return on equity20.3%-1.9pp

Debt / equity0.2×0.0×

Current ratio3.3×+0.3×

Where this comes from

Reported directly by Inter Parfums in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: Inter Parfums’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inter Parfums's indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inter Parfums's indefinite- lived intangible impairment?: Inter Parfums (IPAR) reported indefinite- lived intangible impairment of $447.63M in Q4 2025.
What is the long-term trend for Inter Parfums's indefinite- lived intangible impairment?: Over 2 years (2023 to 2025), Inter Parfums's indefinite- lived intangible impairment has grown at a 7.6% compound annual growth rate (CAGR), from $386.34M to $447.63M.